Complaints Outcomes

Search

Search Results

Search Again
Shareei, Mostafa (Dec 13, 2018)
  1. Nature of Action: The Inquiry Committee of the College of Pharmacists of British Columbia (“CPBC”) conducted an investigation into the practice of Mostafa Shareei (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183.

The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  1. Effective date: December 13, 2018
  1. Name of registrant: Mostafa Shareei
  1. Location of Practice: Vancouver, BC
  1. Admissions and Acknowledgements:

Between July 20, 2016 and December 22, 2016, while he was owner, manager and pharmacist, several pharmacy practice deficiencies were identified.

The Registrant has admitted and/or acknowledged the following:

  1. He provided cash incentives in exchange for daily dispense prescriptions;
  2. He was aware and allowed the pharmacy to operate without a pharmacist present;
  3. He allowed non-pharmacist staff to provide methadone for witness ingestion to patients;
  4. He knew or should have known that a pharmacist/patient consultation was required for new and refill daily dispense prescriptions;
  5. He entered and did not reverse daily dispense prescriptions on PharmaNet when the patient did not attend the pharmacy;
  6. He dispensed prescriptions contrary to the prescriber’s instructions (by providing missed doses and advancing doses for a prescription that was required to be daily dispensed);
  7. He backdated prescriptions on PharmaNet (meaning that dispensing records for these prescriptions were created on dates later than the dates on which the drugs in questions were actually dispensed);
  8. He dispensed prescriptions without prescription labels; and
  9. He provided a Schedule I drug without a prescription.   
  1. Disposition:

The Registrant entered into a Consent Agreement with the Inquiry Committee of CPBC, wherein the Registrant consented to the following terms (in part):

  1. To suspend his registration as a pharmacist for 180 consecutive days commencing January 4, 2019.
  2. To not be a pharmacy manager, director, owner (direct or indirect), shareholder in a corporation that owns a pharmacy and preceptor for a period of five years from the date that his suspension ends;
  3. At his own costs, to complete and pass an ethics course for healthcare professionals;
  4. To pay a $15,000.00 fine; and
  5. To have a Letter of Reprimand placed on his registration record.
  1. Rationale:

The Inquiry Committee determined that the Registrant’s conduct raised serious concerns about his ethical and professional standards in the course of his practice at the pharmacy as a pharmacist, pharmacy manager and owner. Although this was the Registrant’s first encounter with the Inquiry Committee, they determined that his poor standard of practice warranted limits and conditions imposed on his licence, in addition to a fine and a requirement to take an ethics course in order to come into compliance.

The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession. 

Mai , Ha Van Phan (Dec 3, 2018)
  1. Nature of Action: The Inquiry Committee of the College of Pharmacists of British Columbia (the “College”) conducted an investigation into the practice of Ha Van Phan Mai (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183.

The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  1. Effective date: December 3, 2018
  1. Name of registrant: Ha Van Phan Mai
  1. Location of Practice: Vancouver, BC
  1. Admissions and Acknowledgements:

Between January 1, 2014 and November 5, 2017, over 15,000 transactions for over-the-counter (“OTC”) and/or vitamin products were processed on a daily or weekly basis on the PharmaNet records of seven individuals. These seven individuals were not prescribed and had not received any of the OTC and/or vitamin products processed on their PharmaNet records, and had not consented to having these transactions on their PharmaNet records.

These transactions all originated from a pharmacy where the Registrant had worked as a full-time pharmacist.

The pharmacy’s manager at the time had directed pharmacy assistants to process these transactions on PharmaNet every Sunday in order to artificially inflate the pharmacy’s prescription count. The pharmacy assistants used the registration numbers of various pharmacist registrants as the dispensing pharmacist and/or prescriber for each transaction, without the consent and knowledge of these pharmacist registrants.

The Registrant has admitted and/or acknowledged the following:

  1. She was aware that the pharmacy’s manager directed the processing of the transactions in order to artificially inflate the pharmacy’s prescription count;
     
  2. When she had been the pharmacist on duty, she did not directly supervise the activities of the pharmacy assistants that had processed the transactions on Sundays;
     
  3. She knew, or should have known, that:
    1. The processing of the transactions was an improper use and access of personal information;
       
    2. There was no patient consent to process the transactions;
       
    3. Pharmacy assistants are always to be directly supervised; and
       
    4. Pharmacists must personally review the PharmaNet record for all prescriptions processed;
       
  4. Even though she knew about these transactions, she did not, at any time, make a report to the College about them.
  1. Disposition:

The Registrant entered into a Consent Agreement with the College’s Inquiry Committee, wherein the Registrant consented to the following terms

  1. To successfully complete and pass an ethics course for healthcare professionals within six months. If she fails to complete this within the specified time period, her registration will be suspended for a period of 30 days;
     
  2. To successfully pass the College’s Jurisprudence Exam;
     
  3. To successfully complete and pass the “BC Community Pharmacy Manager Training Program” offered by the British Columbia Pharmacy Association; and
     
  4. To have a Letter of Reprimand placed permanently on her registration record.
  1. Rationale:

The Inquiry Committee was concerned that the Registrant did not take personal accountability and “turned a blind eye” to the improper practices for which she was aware, enabling the improper practices to continue for over three years. While the Registrant did not stand to gain financially from what occurred, it was her professional responsibility, to the public as well as the profession, to ensure that practice and ethical standards were being met at all times while on duty. As a member of a professional body, registrants are responsible not only for their own actions, but are accountable for others in the workplace when they know, or ought to know, that inappropriate practices were occurring and ongoing. Her actions, or lack thereof, were contraventions of legislation involving protection of personal information and supervision of pharmacy assistants, She also contravened standards of the Code of Ethics involving protecting and promoting the well-being of patients, benefitting society, and committing to personal and professional integrity.

The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession. Inappropriate access of personal health information, without consent, compromises the public’s trust in the pharmacy profession as a whole. At all times, registrants must uphold legislative requirements and ethical obligations to protect personal health information.

Lu, William Wanyang (Nov 30, 2018)
  1. Nature of Action: The Inquiry Committee of the College of Pharmacists of British Columbia (the “College”) conducted an investigation into the practice of William Wanyang Lu (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183.

The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  1. Effective date: November 30, 2018
  1. Name of registrant: William Wanyang Lu
  1. Location of Practice: Vancouver, BC
  1. Admissions and Acknowledgements:

Between January 1, 2014 and November 5, 2017, over 15,000 transactions for over-the-counter (“OTC”) and/or vitamin products were processed on a daily or weekly basis on the PharmaNet records of seven individuals. These seven individuals were not prescribed and had not received any of the OTC and/or vitamin products processed on their PharmaNet records, and had not consented to having these transactions on their PharmaNet records.

These transactions all originated from a pharmacy where the Registrant had worked as a full-time pharmacist.

The pharmacy’s manager at the time had directed pharmacy assistants to process these transactions on PharmaNet every Sunday in order to artificially inflate the pharmacy’s prescription count. The pharmacy assistants used the registration numbers of various pharmacist registrants as the dispensing pharmacist and/or prescriber for each transaction, without the consent and knowledge of these pharmacist registrants.

The Registrant has admitted and/or acknowledged the following:

  1. He was aware that the pharmacy’s manager directed the processing of the transactions in order to artificially inflate the pharmacy’s prescription count;
     
  2. When he had been the pharmacist on duty, he did not directly supervise the activities of the pharmacy assistants that had processed the transactions on Sundays;
     
  3. He knew, or should have known, that:
    1. The processing of the transactions was an improper use and access of personal information;
       
    2. There was no patient consent to process the transactions;
       
    3. Pharmacy assistants are always to be directly supervised; and
       
    4. Pharmacists must personally review the PharmaNet record for all prescriptions processed;
       
  4. Even though he knew about these transactions, he did not, at any time, make a report to the College about them.
  1. Disposition:

The Registrant entered into a Consent Agreement with the College’s Inquiry Committee, wherein the Registrant consented to the following terms:

  1. To successfully complete and pass an ethics course for healthcare professionals within six months. If he fails to complete this within the specified time period, his registration will be suspended for a period of 30 days;
     
  2. To successfully pass the College’s Jurisprudence Exam;
     
  3. To successfully complete and pass the “BC Community Pharmacy Manager Training Program” offered by the British Columbia Pharmacy Association; and
     
  4. To have a Letter of Reprimand placed permanently on his registration record.
  1. Rationale:

The Inquiry Committee was concerned that the Registrant did not take personal accountability and “turned a blind eye” to the improper practices for which he was aware, enabling the improper practices to continue for over three years. While the Registrant did not stand to gain financially from what occurred, it was his professional responsibility, to the public as well as the profession, to ensure that practice and ethical standards were being met at all times while on duty. As a member of a professional body, registrants are responsible not only for their own actions, but are accountable for others in the workplace when they know, or ought to know, that inappropriate practices were occurring and ongoing. His actions, or lack thereof, were contraventions of legislation involving protection of personal information and supervision of pharmacy assistants, He also contravened standards of the Code of Ethics involving protecting and promoting the well-being of patients, benefitting society, and committing to personal and professional integrity.

The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession. Inappropriate access of personal health information, without consent, compromises the public’s trust in the pharmacy profession as a whole. At all times, registrants must uphold legislative requirements and ethical obligations to protect personal health information.

Wong, Jason Jonathan (Nov 27, 2018)
  1. Nature of Action: The Inquiry Committee of the College of Pharmacists of British Columbia (the “College”) conducted an investigation into the practice of Jason Jonathan Wong (the “Registrant”), pursuant to section 33(4) of the Health Professions Act, R.S.B.C. 1996, c. 183.

    The Inquiry Committee and the Registrant have agreed to resolve all matters arising from the investigation by way of a Consent Agreement under section 36(1) of the Health Professions Act.

  2. Effective date: November 27, 2018

  3. Name of registrant: Jason Jonathan Wong

  4. Location of Practice: Port Coquitlam, BC

  5. Admissions and Acknowledgements:

    Between January 1, 2014 and November 5, 2017, over 15,000 transactions for over-the-counter (“OTC”) and/or vitamin products were processed on a daily or weekly basis on the PharmaNet records of seven individuals. These seven individuals were not prescribed and had not received any of the OTC and/or vitamin products processed on their PharmaNet records, and had not consented to having these transactions on their PharmaNet records.

    These transactions all originated from a pharmacy where the Registrant had worked as a full-time pharmacist.

    The pharmacy’s manager at the time had directed pharmacy assistants to process these transactions on PharmaNet every Sunday in order to artificially inflate the pharmacy’s prescription count. The pharmacy assistants used the registration numbers of various pharmacist registrants as the dispensing pharmacist and/or prescriber for each transaction, without the consent and knowledge of these pharmacist registrants.

    The Registrant has admitted and/or acknowledged the following:

    1. He was aware that the pharmacy’s manager directed the processing of the transactions in order to artificially inflate the pharmacy’s prescription count;
       
    2. When he had been the pharmacist on duty, he did not directly supervise the activities of the pharmacy assistants that had processed the transactions on Sundays;
       
    3. He knew, or should have known, that:
      1. The processing of the transactions was an improper use and access of personal information;
         
      2. There was no patient consent to process the transactions;
         
      3. Pharmacy assistants are always to be directly supervised; and
         
      4. Pharmacists must personally review the PharmaNet record for all prescriptions processed;
         
    4. Even though he knew about these transactions, he did not, at any time, make a report to the College about them.
       
  6. Disposition:

    The Registrant entered into a Consent Agreement with the College’s Inquiry Committee, wherein the Registrant consented to the following terms:

    1. To suspend his registration as a pharmacist for a total of 60 days, commencing November 27, 2018;
       
    2. To successfully pass the College’s Jurisprudence Exam;
       
    3. To successfully complete and pass an ethics course for healthcare professionals;
       
    4. To successfully complete and pass the “BC Community Pharmacy Manager Training Program” offered by the British Columbia Pharmacy Association;
       
    5. To appear before the Inquiry Committee for a verbal reprimand; and
       
    6. To have a Letter of Reprimand placed permanently on his registration record.

     

  7. Rationale:

    The Inquiry Committee was concerned that the Registrant did not take personal accountability and “turned a blind eye” to the improper practices for which he was aware, enabling the improper practices to continue for over three years. While the Registrant did not stand to gain financially from what occurred, it was his professional responsibility, to the public as well as the profession, to ensure that practice and ethical standards were being met at all times while on duty. As a member of a professional body, registrants are responsible not only for their own actions, but are accountable for others in the workplace when they know, or ought to know, that inappropriate practices were occurring and ongoing. His actions, or lack thereof, were contraventions of legislation involving protection of personal information and supervision of pharmacy assistants, He also contravened standards of the Code of Ethics involving protecting and promoting the well-being of patients, benefitting society, and committing to personal and professional integrity.

    The Inquiry Committee also considered that the Registrant had previously consented to remedial undertakings to fully comply with ethical requirements, and he had breached these undertakings for this current matter. The Inquiry Committee therefore considered the Registrant’s conduct to be serious, and that the Registrant required significant remediation and deterrence in order to come into compliance.

    The Inquiry Committee considered the terms of the Consent Agreement necessary to protect the public, as well as send a clear message of deterrence to the profession. Inappropriate access of personal health information, without consent, compromises the public’s trust in the pharmacy profession as a whole. At all times, registrants must uphold legislative requirements and ethical obligations to protect personal health information.

Tahmasebi Boldaji, Ashkan (Oct 10, 2018)

Pursuant to section 36(1) of the Health Professions Act, the Inquiry Committee has reached an Agreement with Ashkan Tahmasebi Boldaji (the “Registrant”) to suspend his registration as a pharmacist for 30 consecutive days commencing December 4, 2018.

While the Registrant was delivering medications to a transitional housing complex the Registrant shoved and pushed a resident of this home out of an elevator resulting in her falling to the ground. The resident appeared to enter the elevator smoking a cigarette and did not put it out when asked by the Registrant. There was no evidence to support a need for self-defence by the Registrant. Additionally, the Registrant’s statements were found to be inconsistent with video evidence.

The Registrant acknowledged that his conduct constituted professional misconduct.

Pursuant to his Agreement, the Registrant also consented to the following:

  • To successfully complete an ethics course for healthcare professionals;
  • To appear before the Inquiry Committee for a verbal reprimand; and
  • To pay a $1000.00 fine.

The Inquiry Committee considers this agreement necessary to protect the public, and to send a clear message to the profession that the College does not tolerate this type of conduct.”

Pharmacy Technician Registrant 4 (Oct 3, 2018)

The Inquiry Committee of the College of Pharmacists of British Columbia (“CPBC”) has reached an agreement with the pharmacy technician registrant to voluntarily suspend her registration as pharmacy technician effective October 3, 2018. The agreement remains in effect until further notice. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacy technician’s name has been withheld pursuant to section 39.3(4)(a) of the Health Professions Act.

Zhao, David (Aug 19, 2018)

Pursuant to section 36(1) of the Health Professions Act, the Inquiry Committee has reached an Agreement with David Zhao (the “Registrant”) to suspend his registration as a pharmacist for 365 consecutive days commencing September 4, 2018.

The Registrant acknowledged that between March 6, 2016 and January 18, 2017, while engaged in the practice of pharmacy as a pharmacist and pharmacy manager, he processed 526 false prescription claims to his insurance provider for reimbursement. The Registrant acknowledged that by processing false prescriptions, he also falsified pharmacy drug and inventory records.

The Registrant also acknowledged that while he was pharmacy manager, he was responsible for multiple practice deficiencies including processing prescriptions for his family members to artificially increase the pharmacy’s prescription count, engaging in a conflict of interest, and backdating prescriptions (meaning that dispensing records for these prescriptions were created on dates later than the dates on which the drugs in question were actually dispensed).

Prior to reinstatement of his registration following the suspension period, the Registrant will be required to:

  • Meet with the Inquiry Committee to discuss his reflections on his conduct and what he has learned; and
  • Complete an ethics course at his own expense.

The Registrant will also be limited from being a manager, direct owner and/or indirect owner of a pharmacy for a period of three years from the date his suspension ends (commencing September 4, 2019).

The Inquiry Committee considers this agreement necessary to protect the public, as well as send a clear message to the profession that the College does not tolerate this type of conduct. 

Phalore, Jagbir (Aug 3, 2018)

The Inquiry Committee has reviewed information that indicates Mr. Phalore’s practice is now meeting practice standards. Therefore, after reviewing and reconsidering this case, the Inquiry Committee determined that the current limits and conditions on Mr. Phalore’s practice are no longer necessary.

Limits and conditions on Mr. Phalore’s practice have now been removed.


November 29, 2016
(August 3, 2018 – Limits and conditions removed)

Pursuant to s. 35(4) of the Health Professions Act, the Inquiry Committee has determined that the limits and conditions imposed on the practice of pharmacy by Mr. Jagbir Phalore on May 16, 2016 are no longer necessary.

Pursuant to s. 36(1) of the Health Professions Act, the Inquiry Committee has reached an agreement with Mr. Phalore, effective November 29, 2016, where he undertaken to always follow certain steps in his pharmacy practice, and to disclose these undertakings to employers and potential employers. He will also be restricted from acting the following roles in his practice:

  1. Be an owner or manager of a pharmacy;
  2. Be a director of a corporation that owns a pharmacy; and
  3. Act as a preceptor.

After two years from November 29, 2016, Mr. Phalore may request that the Inquiry Committee remove the above limits and conditions, subject to a further review of the case by the Inquiry Committee.


May 16, 2016
(November 29, 2016 - Limits and conditions updated) 

The Inquiry Committee, pursuant to Section 35(1) of the Health Professions Act, R.S.B.C. 1996, c. 183, for the purposes of public protection, has imposed limits and conditions on the practice of registrant Jagbir Phalore, effective immediately, pending a Practice Audit of his pharmacy practice. Until further notice, Mr. Phalore has the following limits and conditions on his practice:

  1. At all times, he must work under the direct supervision of a BC licensed pharmacist in good standing, similar to a student/preceptor situation; 

  2. He will be restricted from acting in the following roles in his practice: :

    1. Be an owner or manager of a pharmacy;
    2. Be a director of a corporation that owns a pharmacy; and
    3. Act as a preceptor.

     

  3. Prior to the commencement of new employment at any pharmacy, he will inform every manager and employer of the pharmacy in which he gains employment of the limits and conditions on his license pursuant to this order, and will ensure that the pharmacy manager and employer submits a written statement to the College declaring their awareness of the limits and conditions and how the limits and conditions will be accommodated in the pharmacy.

The Inquiry Committee considered this action necessary to protect the public, due to its concerns regarding the registrant’s ability to practice safely and to comply with legislative requirements and practice standards in a hospital and/or community pharmacy setting.

Pharmacist Registrant 36 (Jun 10, 2018)

The Inquiry Committee, pursuant to section 36 of the Health Professions Act, has reached an Agreement with pharmacist registrant to suspend registration as a pharmacist for an indefinite period pending further decision of the Inquiry Committee. The Inquiry Committee considers the Agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act

Sanchez, Isidoro Andres “Rudy” / Marigold Compounding and Natural Pharmacy (Jun 1, 2018)

On June 1, 2018, a Panel of the Discipline Committee, pursuant to sections 39(1)(a) and 39(1)(c) of the Health Professions Act, found that Isidoro Andres “Rudy” Sanchez  of Courtenay, British Columbia, Registration No. 03593 (the "Registrant") engaged in unprofessional conduct and failed to comply with the Health Professions Act, its regulations and bylaws and the Pharmacy Operations and Drug Scheduling Act and its bylaws.

Pursuant to section 39(2) of the Health Professions Act, the Panel issued an order to immediately cancel the Registrant’s registration and for the Registrant to pays costs in the amount of $115,000.00. The Registrant will only be eligible to apply for reinstatement of registration six years following the Panel’s order and after having paid costs in full. If the Registrant’s registration is reinstated, he will not be eligible to apply for a pharmacy license or act as a pharmacy manager or director for a period of five years following reinstatement.


January 30, 2015
(June 1, 2018 - Registration Cancelled)

Pursuant to s. 33(6)(d) of the Health Professions Act, the Inquiry Committee directed the Registrar to issue a citation for a hearing by the Discipline Committee regarding Mr. Sanchez and Marigold Pharmacy.


September 26, 2014
(January 30, 2015 – Directed Registrar to issue Citation for hearing by Discipline Committee)

 

Pursuant to s. 35(1) of the Health Professions Act, [RSBC 1996] Chapter 183, the Inquiry Committee made an extraordinary order to suspend the licences of Marigold Compounding and Natural Pharmacy (“Marigold Pharmacy”) and its manager, Mr. Isidoro “Andres Rudy” Sanchez, effective September 26, 2014, pending completion of its investigation of Marigold Pharmacy.  This order was made in the interest of public safety following a large-scale investigation which raised serious concerns with respect to the pharmacy practice of Mr. Sanchez at Marigold Pharmacy, including but not limited to:

  • Manufacturing and selling prescription, over-the-counter and natural health products on site at Marigold Pharmacy without valid licences from Health Canada
  • Non-compliance with prescribed standards for pharmacy practice and pharmacy management
  • Making therapeutic and product recommendations to patients outside the scope of pharmacy practice
  • Handling and preparing placenta for encapsulation without regulatory clearance required for ensuring safety of said biologic materials
  • Failure to comply with compounding standards

This investigation is currently on-going.  Until further notice, the pharmacist licence of Mr. Sanchez as well as the licence of Marigold Pharmacy are suspended, pending completion of the investigation.

Pages